VC / M&A News
Most Popular VC / M&A Story
Merck jumps in the biotech VC game with $250M plan
Big Pharma is betting more big bucks on early-stage biotech. As drugmakers seek more external sources of new products to feed their rusty R&D pipelines, drug giant Merck ($MRK) has plans to pump Read more...
Latest Headlines
- January 13, 2012
- September 15, 2011
- April 10, 2008
- April 3, 2008
- April 2, 2008
- August 2, 2007
- August 2, 2007
- August 1, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
